We are live on ! Find out more
ACET icon

Adicet Bio
ACET

87 hedge funds and large institutions have $630M invested in Adicet Bio in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more funds holding in top 10

Funds holding in top 10: 5 → 9 (+4)

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

45% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 22

25% more capital invested

Capital invested by funds: $504M → $630M (+$125M)

7% more funds holding

Funds holding: 81 → 87 (+6)

0.22% more ownership

Funds ownership: 4.97% → 5.19% (+0.22%)

13% less call options, than puts

Call options by funds: $1.76M | Put options by funds: $2.02M

Holders
87
Holders Change
+6
Holders Change %
+7.41%
% of All Funds
1.37%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.14%
New
17
Increased
32
Reduced
22
Closed
11
Calls
$1.76M
Puts
$2.02M
Net Calls
-$259K
Net Calls Change
-$1.62M

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$21.6M
2
Deutsche Bank
Deutsche Bank
Germany
+$9.34M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.38M
4
WP
Woodline Partners
California
+$2.82M
5
BlackRock
BlackRock
New York
+$2.38M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.83M
2
Two Sigma Investments
Two Sigma Investments
New York
-$4.47M
3
Walleye Capital
Walleye Capital
New York
-$3.63M
4
SFM
Sphera Funds Management
Israel
-$2.62M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$2.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$4.42M +$124K +541 +4%
Northern Trust
27
Northern Trust
Illinois
$4.08M +$498K +2,166 +20%
GPCM
28
Granite Point Capital Management
Massachusetts
$3.95M – – –
WP
29
Woodline Partners
California
$3.92M +$2.82M +12,282 New
Baillie Gifford & Co
30
Baillie Gifford & Co
United Kingdom
$3.63M – – –
FCOMV
31
Foresite Capital Opportunity Management V
California
$3.4M – – –
ACM
32
Altium Capital Management
New York
$3.1M -$1.55M -6,750 -41%
EI
33
EAM Investors
California
$2.63M +$1.89M +8,236 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$2.44M +$213K +925 +14%
Invesco
35
Invesco
Georgia
$2.06M +$1.49M +6,464 New
EGI
36
EAM Global Investors
California
$1.84M +$1.33M +5,763 New
Citadel Advisors
37
Citadel Advisors
Florida
$1.83M +$778K +3,383 +144%
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
$1.57M +$745K +3,239 +193%
Charles Schwab
39
Charles Schwab
California
$1.33M +$217K +945 +29%
PVI
40
Pura Vida Investments
New York
$1.33M -$1.01M -4,387 -51%
TCM
41
Tekla Capital Management
Massachusetts
$1.26M – – –
N
42
Nuveen
North Carolina
$1.23M +$414K +1,799 +54%
Allianz Asset Management
43
Allianz Asset Management
Germany
$1.18M +$292K +1,271 +52%
BFM
44
Boothbay Fund Management
New York
$1.01M – – –
Bank of America
45
Bank of America
North Carolina
$710K -$542K -2,358 -51%
Connor, Clark & Lunn Investment Management (CC&L)
46
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$698K +$111K +481 +28%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$633K +$132K +573 +41%
GSEP
48
Golden State Equity Partners
California
$599K +$230 +1 +0.1%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$559K +$403K +1,750 New
JF
50
Jump Financial
Illinois
$467K -$177K -768 -34%
1
2
3 4

ACET Hedge Fund Activity: Q1 2022 in Review

87 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q1 2022, worth a combined $630M — up 25% from $504M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ACET positions and 11 closed out — a net gain of 6 holders — while 32 added to existing stakes and 22 trimmed.

The largest buyer was Cowen and Company, opening a new position worth an estimated $21.6M. The largest seller was Point72 Asset Management, cutting an estimated $5.83M.

  • 87 institutional investors held Adicet Bio (ACET) as of Q1 2022, up from 81 in Q4 2021.
  • Funds reported $630M of Adicet Bio stock for Q1 2022, up 25% quarter-over-quarter.
  • 17 funds opened new Adicet Bio positions in Q1 2022 and 11 closed out, a net change of +6 holders.
  • The largest Adicet Bio buyer in Q1 2022 was Cowen and Company, an estimated $21.6M added.
  • The largest Adicet Bio seller in Q1 2022 was Point72 Asset Management, an estimated $5.83M sold.

Based on aggregated 13F filings for Q1 2022.